Very Early Nimodipine Use in Stroke (VENUS): a randomized, double-blind, placebo-controlled trial.

@article{Horn2001VeryEN,
  title={Very Early Nimodipine Use in Stroke (VENUS): a randomized, double-blind, placebo-controlled trial.},
  author={Janneke Horn and Rob J. de Haan and Marinus Vermeulen and Martien Limburg},
  journal={Stroke},
  year={2001},
  volume={32 2},
  pages={461-5}
}
BACKGROUND AND PURPOSE The Very Early Nimodipine Use in Stroke (VENUS) trial was designed to test the hypothesis that early treatment with nimodipine has a positive effect on survival and functional outcome after stroke. This was suggested in a previous meta-analysis on the use of nimodipine in stroke. However, in a recent Cochrane review we were unable to reproduce these positive results. This led to the early termination of VENUS after an interim analysis. METHODS In this randomized, double… CONTINUE READING